Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001493152-25-029450
Filing Date
2025-12-29
Accepted
2025-12-29 17:28:05
Documents
13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15441
2 PART II AND III partiiandiii.htm PART II AND III 880245
3 ADD EXHB ex1-1.htm ADD EXHB 196307
4 ADD EXHB ex2-3.htm ADD EXHB 108395
5 ADD EXHB ex3-6.htm ADD EXHB 109251
6 ADD EXHB ex3-7.htm ADD EXHB 244416
7 ADD EXHB ex4-1.htm ADD EXHB 59259
8 ADD EXHB ex8-1.htm ADD EXHB 103351
9 ADD EXHB ex11-1.htm ADD EXHB 5690
10 ADD EXHB ex12-1.htm ADD EXHB 31627
11 GRAPHIC forrm1-a_001.jpg GRAPHIC 6629
12 GRAPHIC ex8-1_001.jpg GRAPHIC 2658
13 GRAPHIC ex12-1_001.jpg GRAPHIC 2687
  Complete submission text file 0001493152-25-029450.txt   1772220
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-12688 | Film No.: 251610437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)